ImmunoCellular amends follow-on

ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Calabasas, Calif.
Business: Cancer
Date

Read the full 92 word article

How to gain access

Continue reading with a
two-week free trial.